Skip to main content
Download PDF
  • Research note
  • Open access
  • Published:

Factors associated with HIV and syphilis screenings among pregnant women at first antenatal visit in Lusaka, Zambia

BMC Research Notes volume 13, Article number: 423 (2020) Cite this article

Abstract

Objectives

To identify characteristics associated with obtaining HIV and syphilis screenings of pregnant women attending a first antenatal visit in Lusaka, Zambia.

Results

Among 18,231 participants from April 2015 to January 2016, 95% obtained HIV screening, 29% obtained syphilis screening, and 4% did not obtain antenatal HIV or syphilis screenings. Divorced/separated women were associated with a moderate decrease in prevalence of obtaining HIV (adjusted prevalence ratio (aPR) 0.88, 95% confidence interval (95% CI) 0.82, 0.95) and syphilis (aPR 0.51, 95% CI 0.27, 0.96) screenings compared to married women. Women with previous pregnancies were associated with a slight decrease in prevalence of obtaining HIV screening (aPR 0.97, 95% CI 0.95, 0.99) compared to women without previous pregnancy. Older women ≥ 35 years were associated with a slight decrease in prevalence of obtaining HIV screening (aPR 0.96, 95% CI 0.92, 0.99) compared to younger women. The statistically significant differences were not of clinical relevance as defined by a proportional difference of 10 percent. Findings of this study show that a vast majority of pregnant women are obtaining HIV screenings but not syphilis screenings during first antenatal visit. Provision of antenatal HIV and syphilis screening at first visit is only weakly related to patient level factors.

Introduction

Despite advances in antenatal recommendations and treatment to prevent mother to child transmission (PMTCT) of HIV and syphilis, congenital infections represent a major global public health burden. The most effective method of prevention of mother to child transmission of HIV is to reduce maternal viral load through antiretroviral therapy (ART) during pregnancy and breastfeeding [1]. Without provision of antiretroviral treatment, the rate of vertical transmission of HIV can range from 15 to 45% [2, 3]. For prevention of congenital syphilis, one dose of benzathine penicillin G is effective treatment to prevent mother to child transmission of syphilis [4]. A single dose is sufficient to treat early syphilis, but syphilis of longer duration requires three doses to assure cure. Untreated syphilis can lead to fetal loss or stillbirth during pregnancy and surviving infants can be born preterm, low birth weight, or have active syphilis infection [5]. In addition, syphilis positive pregnant women are twice as likely to be HIV seropositive [6].

Antenatal screenings are a key step in prevention of HIV and syphilis transmission in order to identify seropositive women and start respective treatments [7, 8]. A focus on both HIV and syphilis screening during antenatal care has proven to be feasible, cost-effective, and prevent adverse birth outcomes [9,10,11,12]. Overall among women attending antenatal care in sub-Saharan Africa, approximately 60% of pregnant women received HIV testing and under 40% of pregnant women received syphilis testing [13, 14]. Specifically in Zambia, HIV screening of pregnant women was estimated to be 94% and syphilis screening was 85% during 2010–2013 [15].

Antenatal HIV and syphilis screenings are not universal in Zambia and greater sub-Saharan Africa [13, 16, 17]. Exploring individual level characteristics associated with antenatal HIV and syphilis screenings can better describe the current situation and assist with creating more targeted interventions to increase the provision of antenatal screenings. Previous studies have reported mixed findings on the association between women obtaining antenatal HIV and syphilis screenings during pregnancy and individual level characteristics such as age, adverse pregnancy outcomes, and marital status [18,19,20,21,22]. In addition, prior research focused on individual level factors associated with antenatal HIV or syphilis screenings have reported findings on either antenatal HIV or syphilis screenings. The objective of this present study was to identify clinically relevant individual factors associated with HIV and syphilis screenings at first antenatal visit in Lusaka, Zambia.

Main text

Methods

This is a cross-sectional study focusing on 13 Lusaka district clinics participating in the nine month baseline period of Preventing Congenital Syphilis (PCS), a facility-based, two-arm parallel cluster randomized implementation trial (ClinicalTrials.gov: NCT02353117; registered on February 2, 2015) [23]. The objective of the PCS implementation trial was to evaluate a behavioral multifaceted intervention to increase the use of evidence-based clinical procedures to increase syphilis screening and treatment during antenatal care in antenatal clinics in Kinshasa, Democratic Republic of the Congo and Lusaka, Zambia [24, 25].

The 13 antenatal clinics participating in the baseline period were selected based on geographic location within areas of Kafue and Chongwe located in the capital province of Lusaka. These health facilities that are designated as urban health centers with PMTCT programs in Lusaka District (91). During the baseline period, all women attending their first antenatal care visit at one of the 13 participating clinics during April 13, 2015 to January 10, 2016 were approached for study enrollment [24].

The inclusion criterion for this study included all consenting women who attended an antenatal care visit for the first time at one of the participating clinics in Lusaka, Zambia from April 2015 to January 2016 and recorded within the PCS baseline database. Women with completed data were included in the analyses. Antenatal care is defined as care during pregnancy before the initiation of labor. A first antenatal care visit is defined as the first visit at a participating health care facility during the current pregnancy. Exclusion criteria included women who did not/were unable to provide consent.

For enrolled participants, study personnel completed an antenatal care form at clinics [24]. Data was also collected from multiple source documents including antenatal care registry, antenatal card, PMTCT books, laboratory records, and nurses’ books [24]. Unavailable data from the source documents were collected from the mothers [24]. During the baseline data period, the study team produced detailed weekly and monthly data monitoring reports. Weekly calls and monitoring visits were made to continuously monitor study activities and data quality.

Statistical analyses

The unit of data analysis is a pregnant woman. Data are summarized as count and percentage for all categorical variables. Log-binomial regression model with adjustment for cluster effects was used to estimate crude prevalence ratios (PR) with 95% confidence intervals (95% CI) and adjusted prevalence ratios (aPR) with 95% CI to determine which individual level factors were associated with the following dichotomous screening outcomes during first antenatal visit: (1) obtained HIV screening vs. no HIV screening (reference group (ref)) and (2) obtained syphilis screening vs. no syphilis screening (ref). Separate crude and adjusted PRs were calculated for variables pertaining to HIV and/or syphilis screenings among pregnant women with history of previous pregnancy using Poisson regression models with robust variance and adjustment for cluster effects. All aPRs and 95% CIs were adjusted for age, marital status, education, history of known syphilis infection, and previous pregnancy. These variables were selected a priori based on the existing literature [13, 26, 27]. All statistical analyses were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC). Clinical relevance was defined by a proportional difference of 10 percent [28].

Results

This study included 18,231 pregnant women. During first antenatal care visit, 95% of women obtained an HIV screening, 29% of women obtained a syphilis screening, and 4% of women did not obtain antenatal HIV or syphilis screening. Majority of the study participants were between 20 and 34 years of age (76%), married (88%), completed greater than primary school to less than or equal secondary school (55%), and had no history of syphilis infection (98%) (Table 1). Of the 13,396 women with previous pregnancy, 17% had a history of preterm birth, and 4% had a history of previous abortion and/or stillbirth (Table 1).

Table 1 Overall characteristics of pregnant women attending first antenatal care visit in Lusaka, Zambia, 2015–2016
Full size table

Majority of pregnant women had obtained HIV screening among all variable levels of age, marital status, education, history of syphilis infection, and previous pregnancy during first antenatal care visit in Lusaka, Zambia (Table 2). In multivariable regression analyses, pregnant women who were greater than or equal to 35 years of age (aPR = 0.96; 95% CI (0.92, 0.99)), divorced/separated (aPR = 0.88; 95% CI (0.82, 0.95)), had a history of syphilis infection (aPR 1.07, 95% CI 1.01, 1.15), and two or more previous pregnancies (aPR = 0.97; 95% CI (0.95–0.99)) were significantly associated with a decreased prevalence of obtaining an HIV screening.

Table 2 Individual-level characteristics and prevalence ratios for the outcome: pregnant women who obtained a HIV screening
Full size table

Majority of pregnant women did not obtain a syphilis screening at first antenatal visit among all variable levels of age, marital status, education, history of syphilis infection, and previous pregnancy during first antenatal care visit in Lusaka, Zambia (Table 3). Widowed women without a current partner were associated with an increase in prevalence of obtaining syphilis screening (aPR 1.49, 95% CI 1.08, 2.05) compared to married women. Conversely, divorced/separated women had a decrease in prevalence of obtaining syphilis screening (aPR 0.51, 95% CI 0.27, 0.96) compared to married women.

Table 3 Individual-level characteristics and prevalence ratios for the outcome: pregnant women who obtained a syphilis screening
Full size table

Discussion

Provision of screenings during the first antenatal care visit is essential to prevent vertical transmission of HIV and syphilis. However, antenatal HIV and syphilis screening rates vary dramatically across sub-Saharan Africa. Despite evidence demonstrating the cost-effectiveness and beneficial effects of prioritizing both antenatal HIV and syphilis screenings, previous studies have focused on individual level factors associated with either antenatal HIV or syphilis screenings. The current study is one of few that has investigated both types of antenatal screenings concurrently. Results of this study showed that only 29% of pregnant women obtained a syphilis screening compared to 95% of pregnant women who obtained HIV screening at first antenatal visit during the baseline period of the PCS implementation trial. Furthermore, the regression analysis showed limited clinically relevant individual level gaps in antenatal HIV and syphilis screenings among pregnant women attending a first visit. This is a positive finding in that provision of antenatal HIV and syphilis screenings by healthcare providers do not greatly differ by individual patient characteristics.

Education was the most common individual level factor assessed in previous studies. Multiple studies found that higher education among pregnant women was significantly associated with obtaining antenatal HIV and syphilis screenings [18,19,20,21,22]. The present study did not find a significant association between education level and screenings. Majority of participants in this study had received more than a primary education.

In the current study, the results showed a large gap between antenatal syphilis screenings and HIV screening at first visit which could not be attributed to individual level factors. The results of the PCS implementation trial showed that a multifaceted behavioral intervention with provision of supplies, including screening and treatment kits, can lead to more than 95% of pregnant women being screened and treated for syphilis without compromising HIV screening rates in Lusaka, Zambia and Kinshasa, Democratic Republic of the Congo [25]. Improvement of clinic-level factors demonstrated an increase in the provision of antenatal syphilis screenings. The findings of this study should be used to supplement the findings from the PCS implementation trial to inform future antenatal staff trainings, patient education, and future interventions that focus on scaling up antenatal HIV and syphilis screenings.

Limitations

The findings of this study should be interpreted with consideration of study limitations. The cross-sectional design of this study prevents any causal interpretation of the significant associations. The variables available for this secondary analysis were limited and methods of data collection are not specifically designed for the purposes of this cross-sectional study. Although this study has a large sample size, because the health facilities were not randomly selected for the PCS baseline period, generalizability of the study findings should be limited to women attending first antenatal care visit at public clinics in Lusaka district. The findings of this study may also be subject to recall bias as the variables not recorded in clinic source documents are based on self-reports to trained study personnel without verification. Furthermore, the study is also susceptible to social desirability bias as the data collected by research staff reveal medical history and personal information on HIV and syphilis in pregnant women.

Availability of data and materials

The dataset supporting the conclusions of this article is available in the Mendeley Data repository titled, “Factors associated with HIV and syphilis screenings among pregnant women at first antenatal visit in Lusaka, Zambia.” https://data.mendeley.com/datasets/9b5x936n4g/draft?a=b2e6cf3e-8a33-40fe-bad1-8e6f3fedbb4c

Abbreviations

HIV:

Human Immunodeficiency Virus

ART:

Antiretroviral therapy

PMTCT:

Prevention of mother to child transmission

PCS:

Preventing Congenital Syphilis

PR:

Prevalence ratio

aPR:

Adjusted prevalence ratio

References

  1. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection : Recommendations for a Public Health Approach. WHO. Geneva: World Health Organization; 2016. https://www.who.int/hiv/pub/guidelines/arv2013/en/. Accessed 24 Jan 2019.

  2. Newman Owiredu M, Newman L, Nzomo T, Conombo Kafando G, Sanni S, Shaffer N, et al. Elimination of mother-to-child transmission of HIV and syphilis: a dual approach in the African Region to improve quality of antenatal care and integrated disease control. Int J Gynecol Obstet. 2015;130(2015):S27–31.

    Google Scholar 

  3. WHO | Prevention of mother-to-child transmission (PMTCT). WHO. 2018. http://www.who.int/gho/hiv/epidemic_response/PMTCT_text/en/. Accessed 27 Mar 2018.

  4. Syphilis. 2015 Sexually Transmitted Diseases Treatment Guidelines. U.S. Department of Health & Human Services; 2015. https://www.cdc.gov/std/tg2015/syphilis.htm. Accessed 10 Aug 2020.

  5. Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Systematic reviews untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Heal Organ. 2013;9112(10):217–26.

    Google Scholar 

  6. WHO | Dual test for syphilis and HIV. WHO. 2014 http://www.who.int/reproductivehealth/topics/rtis/syphilis/dual_test/en/. Accessed 9 Mar 2017.

  7. De Santis M, De Luca C, Mappa I, Spagnuolo T, Licameli A, Straface G, et al. Syphilis Infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol. 2012;2012:430585.

    PubMed  PubMed Central  Google Scholar 

  8. Stringer JS, Sinkala M, Maclean CC, Levy J, Kankasa C, Degroot A, et al. Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS. 2005;19(12):1309–15.

    PubMed  PubMed Central  Google Scholar 

  9. Schackman BR, Neukermans CP, Fontain SNN, Nolte C, Joseph P, Pape JW, et al. Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med. 2007;4(5):e183.

    PubMed  PubMed Central  Google Scholar 

  10. Bristow CC, Larson E, Anderson LJ, Klausner JD. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study. Sex Transm Infect. 2016;92(5):340–6.

    PubMed  PubMed Central  Google Scholar 

  11. Manabe YC, Namale G, Nalintya E, Sempa J, Ratanshi RP, Pakker N, et al. Integration of antenatal syphilis screening in an urban HIV clinic: a feasibility study. BMC Infect Dis. 2015;15(1):1–6.

    Google Scholar 

  12. Strasser S, Bitarakwate E, Gill M, Hoffman HJ, Musana O, Phiri A, et al. Introduction of rapid syphilis testing within prevention of mother-to-child transmission of HIV programs in Uganda and Zambia: a field acceptability and feasibility study. J Acquir Immune Defic Syndr. 2012;61(3):e40–6.

    PubMed  Google Scholar 

  13. Gunn JKL, Asaolu IO, Center KE, Gibson SJ, Wightman P, Ezeanolue EE, et al. Antenatal care and uptake of HIV testing among pregnant women in sub-Saharan Africa: a cross-sectional study. J Int AIDS Soc. 2016;19(1):20605.

    PubMed  PubMed Central  Google Scholar 

  14. Gloyd S, Chai S, Mercer MA. Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction. Health Policy Plan. 2001;16(1):29–34.

    CAS  PubMed  Google Scholar 

  15. Bucher S, Marete I, Tenge C, Liechty EA, Esamai F, Patel A, et al. A prospective observational description of frequency and timing of antenatal care attendance and coverage of selected interventions from sites in Argentina, Guatemala, India, Kenya, Pakistan and Zambia. Reprod Health. 2015;12(Suppl 2):S12.

    PubMed  PubMed Central  Google Scholar 

  16. Kuznik A, Lamorde M, Nyabigambo A, Manabe YC. Antenatal syphilis screening using point-of-care testing in sub-Saharan African countries: a cost-effectiveness analysis. PLoS Med. 2013;10(11):e1001545.

    PubMed  PubMed Central  Google Scholar 

  17. Muyunda B, Mee P, Todd J, Musonda P, Michelo C. Estimating levels of HIV testing coverage and use in prevention of mother-to-child transmission among women of reproductive age in Zambia. Arch Public Heal. 2018;76(1):1–9.

    Google Scholar 

  18. Tran TC, Pillonel J, Cazein F, Sommen C, Bonnet C, Blondel B, et al. Antenatal HIV screening: results from the National Perinatal Survey, France. 2016. Euro Surveill. 2019;24(40):1800573.

    PubMed Central  Google Scholar 

  19. de Freitas M, Forte FDS, Roncalli AG, Galvão MHR, Coelho AA, Dias SMF. Factors associated with prenatal care and HIV and syphilis testing during pregnancy in primary health care. Rev Saude Publica. 2019;53:76.

    PubMed  PubMed Central  Google Scholar 

  20. Dassah ET, Adu-Sarkodie Y, Mayaud P. Factors associated with failure to screen for syphilis during antenatal care in Ghana: a case control study. BMC Infect Dis. 2015;15(1):125.

    PubMed  PubMed Central  Google Scholar 

  21. Trepka MJ, Bloom S, Zhang G, Kim S, Nobles RE. Inadequate syphilis screening among women with prenatal care in a community with a high syphilis incidence. Sex Transm Dis. 2006;33(11):670–4.

    PubMed  Google Scholar 

  22. Pérez K, Blanch C, Casabona J, Almeda J, Coll O. COBEMB Coverage of HIV testing among pregnant women in Catalonia, Spain: a comparison of self-reporting with medical records. Eur J Public Health. 2004;14(3):261–6.

    PubMed  Google Scholar 

  23. Preventing Congenital Syphilis - Full Text View - ClinicalTrials.gov [Internet]. ClinicalTrials.gov. [cited 2017 Mar 9]. https://clinicaltrials.gov/ct2/show/NCT02353117.

  24. Berrueta M, Cafferata ML, Mwenechanya M, Nkamba Mukadi D, Althabe F, Bergel E, et al. Syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cross-sectional study. Gates Open Res. 2017;1:13.

    PubMed  PubMed Central  Google Scholar 

  25. Althabe F, Chomba E, Tshefu AK, Banda E, Belizán M, Bergel E, et al. A multifaceted intervention to improve syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cluster randomised controlled trial. Lancet Glob Heal. 2019;7(5):e655–63.

    Google Scholar 

  26. Punguyire D, Mahama E, Letsa T, Akweongo P, Sarfo B. Factors associated with syphilis screening uptake among pregnant women in health facilities in Brong Ahafo Region of Ghana. Matern Heal Neonatol Perinatol. 2015;1(1):7.

    Google Scholar 

  27. Ginindza TG, Stefan CD, Tsoka-Gwegweni JM, Dlamini X, Jolly PE, Weiderpass E, et al. Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland. Infect Agent Cancer. 2017;12(1):29.

    PubMed  PubMed Central  Google Scholar 

  28. Page P. Beyond statistical significance: clinical interpretation of rehabilitation research literature. Int J Sports Phys Ther. 2014;9(5):726–36.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the study participants and the Preventing Congenital Syphilis (PCS) working group in Lusaka, Zambia. We would like to especially acknowledge Friday Mwanakalanga and Abigail Mwapule Tembo for their contributions during the baseline period of PCS.

Funding

This work was supported by Bill & Melinda Gates Foundation [OPP1116131]; Fogarty Global Health Fellows UJMT (University of North Carolina, Johns Hopkins University, Morehouse School of Medicine, and Tulane University) Consortium (R25TW009340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA

    Rindcy Davis, Xu Xiong & Pierre Buekens

  2. Department of Global Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA

    John Lefante

  3. Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina

    Fernando Althabe & Maria Luisa Cafferata

  4. University Teaching Hospital, Lusaka, Zambia

    Musaku Mwenechanya, Friday Habulembe Mwanakalanga & Elwyn Chomba

  5. New York, USA

    Rindcy Davis

Authors
  1. Rindcy Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xu Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernando Althabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Lefante
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Luisa Cafferata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Musaku Mwenechanya
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Friday Habulembe Mwanakalanga
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Elwyn Chomba
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pierre Buekens
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RD contributed to study design, data analysis, and drafting of the original manuscript. XX, PB, and MLC contributed to the study design, results interpretation, and revising the manuscript. JF and FA contributed to the data analysis, results interpretation, and revising the manuscript. EC, MM and FHM contributed to the revising of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Rindcy Davis.

Ethics declarations

Ethics approval and consent to participate

The approval for this study was obtained from the Tulane University Institutional Review Board and ERES Converge Institutional Review Board in Zambia. All women who provided written consent and attended an antenatal care visit for the first time at one of the participating clinics in Lusaka, Zambia were included in this study. Anonymity of the respondents was ensured throughout data analysis.

Consent for publication

All authors consent for publication.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Davis, R., Xiong, X., Althabe, F. et al. Factors associated with HIV and syphilis screenings among pregnant women at first antenatal visit in Lusaka, Zambia. BMC Res Notes 13, 423 (2020). https://doi.org/10.1186/s13104-020-05266-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13104-020-05266-0

Keywords

BMC Research Notes

ISSN: 1756-0500

Contact us